For the first time, Sanford Burnham Prebys hosted high school interns from the SPARK program, an initiative by the California Institute for Regenerative Medicine (CIRM) that provides biomedical research opportunities for underrepresented groups throughout California.

The project aims to uncover a potential cause of Alzheimer’s brain pathology 

Assistant Professor Jianhua Zhao, Ph.D., has been awarded a unique and competitive NIH grant to study the molecular machinery of protein recycling and discover new targets for cancer therapies.

This year's Preuss internship program was hosted by the Institue's NCI-designated Cancer Center.

Sanford Burnham Prebys recently hosted a celebration to honor the anniversary of the Institute’s founding. More than 200 scientists, students and staff gathered to commemorate 46 years of world-class biomedical research.

Immunotherapy has revolutionized cancer treatment, but it doesn’t work on many childhood brain tumors. Researchers from Sanford Burnham Prebys are working to change that.

Sanford Burnham Prebys Cancer researchers Ani Deshpande, Brooke Emerling, and Charles Spruck have all been promoted from assistant to associate professor.

The four-year, $2.3 million project could accelerate the development of new therapies for a range of cancers, particularly metastatic breast cancer. It also offers an answer to a longstanding mystery in cancer metabolism. 

Scientists and staff from across the Institute gathered to celebrate LGBTQ+ Pride at Sanford Burnham Prebys by attending a Pride flag raising ceremony

The Fellowship is awarded every two years to a Sanford Burnahm Prebys postdoc leading the charge in their field. 

San Diego group has provided more than $2 million to early-career scientists across the country conducting maverick research on Type 1 diabetes, including the lab run by developmental geneticist Duc Dong at Sanford Burnham Prebys.

Recent breakthroughs from Professor Duc Dong and his team bring great promise to the Alagille community and are also cause for the wider rare disease community to pay attention.